Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Masutaka, Higashimura"'
Autor:
Keita Otaki, Takuya Ozawa, Masato Oda, Toshiki Kitajima, Satoru Hirono, Manabu Isoda, Kiminori Kato, Noboru Ikarashi, Fuyuki Asami, Takashi Saigawa, Yashiro Makiyama, Masutaka Higashimura, Ken Toba, Masato Moriyama, Shiro Minagawa, Yoshifusa Aizawa
Publikováno v:
The Tohoku Journal of Experimental Medicine. 215:299-306
Restenosis is a major problem in percutaneous catheter intervention (PCI) for coronary artery stenosis in patients with acute myocardial infarction. Coronary restenosis arises from intimal hyperplasia, i.e., hyperplasia of the vascular smooth muscle
Autor:
Takashi Kuroha, Masutaka Higashimura, Ken Toba, Masaru Urushiyama, Toshio Yano, Akira Hattori, Yoshifusa Aizawa, Ken Momotsu, Noriko Izumi, Kumiko Yagisawa, Yasuhiko Sibasaki, Kiyoshi Okazuka, Akihito Momoi
Publikováno v:
International journal of hematology. 95(4)
Myelodysplastic syndrome (MDS) is relatively common in the elderly, and aging of populations is progressing in developed nations, notably so in Japan. The major age group in Japan and Sado Island are distributed between 30 and 60 and between 50 and 8
Autor:
Masato Moriyama, Masuhiro Takahashi, Masutaka Higashimura, Akihito Momoi, Masayoshi Masuko, Takashi Abe, Yasuhiko Shibasaki, Miwako Narita, Naoko Sato, Ken Toba, Kiyoshi Okazuka, Tori Kurasaki-Ida, Tatsuo Furukawa, Takashi Kuroha, Yoshifusa Aizawa, Toshio Yano, Kaori Karimata, Jun Takizawa, Ichiro Fuse, Nobuhiro Tsukada
Publikováno v:
International journal of hematology. 92(1)
Pharmacological study is predictably effective in establishing an optimal monitoring strategy for the usage of cyclosporine A (CsA) to prevent graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation recipients. Pharmaco
Autor:
Masato, Oda, Kiminori, Kato, Ken, Toba, Keita, Otaki, Toshiki, Kitajima, Noboru, Ikarashi, Takao, Yanagawa, Masutaka, Higashimura, Fuyuki, Asami, Manabu, Isoda, Takuya, Ozawa, Masato, Moriyama, Satoru, Hirono, Yuji, Okura, Haruo, Hanawa, Makoto, Kodama, Yoshifusa, Aizawa
Publikováno v:
Journal of cardiology. 50(4)
Autologous bone marrow implantation (BMI) is effective to treat critical limb ischemia, but the long-term prognosis is not clear. The outcome of BMI treatment for ischemic legs was investigated related to the clinical background of the patient, and s
Autor:
Toshiki Kitajima, Keiichiro Honma, Hidenobu Takahashi, Sadao Aoki, Tatsuo Furukawa, Tori Kurasaki, Masutaka Higashimura, Akihito Momoi, Naoya Nakamura, Jun Takizawa, Yoshifusa Aizawa
Publikováno v:
American journal of hematology. 82(12)
This study reports the first well-documented case of adult T-cell leukemia (ATL) successfully treated with unrelated cord blood transplantation (UCBT). A 49-year-old woman was diagnosed with acute-type of ATL. Chemotherapy induced complete remission,
Autor:
Toshiki Kitajima, Naoya Nakamura, Akihito Momoi, Sadao Aoki, Jun Takizawa, Yoshifusa Aizawa, Masutaka Higashimura
Publikováno v:
Blood. 108:4620-4620
Background: Diffuse large B-cell lymphoma (DLBCL), which is the most common type of adult non-Hodgkin lymphoma, is considered to be heterogeneous in cytogenetics, immunophenotype and clinical feature. As the results of gene expression profiling, DLBC
Autor:
Sadao Aoki, Kazue Takai, Akihito Momoi, Yoshufusa Aizawa, Masutaka Higashimura, Keiichiro Honma, Tohri Kurasaki, Kouichi Nagai, Koji Nikkuni, Jun Takizawa
Publikováno v:
Blood. 106:4734-4734
Introduction CHOP chemotherapy has been accepted as the standard treatment for patients with non-Hodgkin lymphoma (NHL), but in some histological or clinical subtypes the results are not satisfactory. We have shown the efficacy and safety of high-dos
Autor:
Koji Nikkuni, Yoshifusa Aizawa, Sadao Aoki, Nobuhiko Nomoto, Akihito Momoi, Jun Takizawa, Masutaka Higashimura, Nobuhiro Tsukada
Publikováno v:
Blood. 104:5207-5207
Introduction: Most patients with advanced-stage follicular lymphoma(FL) cannot be cured by conventional chemotherapy and have median survival of 7 to 10 years. High-dose chemotherapy (HDT) supported by autologous stem cell transplantation(ASCT) gives